DiaMedica Therapeutics CEO Rick Pauls' 2023 pay rises 12% to $1.2M
DiaMedica Therapeutics reports 2023 executive compensation
By ExecPay News
Published: April 4, 2024
DiaMedica Therapeutics reported fiscal year 2023 executive compensation information on April 4, 2024.
In 2023, four executives at DiaMedica Therapeutics received on average a compensation package of $744K, a 16% decrease compared to previous year.
Average pay of disclosed executives at DiaMedica Therapeutics
Rick Pauls, Chief Executive Officer, received $1.2M in total, which increased by 12% compared to 2022. 46% of Pauls' compensation, or $562K, was in salary. Pauls also received $240K in non-equity incentive plan, $397K in option awards, as well as $17K in other compensation.
Scott Kellen, Chief Financial Officer, received a compensation package of $632K, which increased by 12% compared to previous year. 56% of the compensation package, or $353K, was in salary.
Kirsten Gruis, Chief Medical Officer, earned $596K in 2023, a 41% decrease compared to previous year.
Julie Daves, SVP, Clinical Development Operations, received $533K in 2023.
Related executives
You may also like
Source: SEC filing on April 4, 2024.